Hagens Berman Sobol Shapiro LLP a national investor-rights law firm, on Apr. 9 said it is investigating Geron Corporation (NASDAQ:GERN) for securities fraud following allegations that the company distributed false and misleading statements to investors concerning its business and prospects, and advises investors of the May 13, 2014 lead plaintiff deadline. Geron Corporation (NASDAQ:GERN) shares after opening at $1.92 moved to $2.29 on last trade day and at the end of the day closed at $2.19. Company price to sales ratio in past twelve months was calculated as 264.33 and price to cash ratio as 5.27. Geron Corporation (NASDAQ:GERN) showed a positive weekly performance of 15.87%.
Idera Pharmaceuticals (NASDAQ:IDRA) surged Tuesday on a positive day for healthcare stocks after the company had remained relatively flat since last week. Idera Pharmaceuticals Inc (NASDAQ:IDRA) shares advanced 16.90% in last trading session and ended the day on $3.32. IDRA return on equity ratio is recorded as -193.60% and its return on assets is -84.10%. Idera Pharmaceuticals Inc (NASDAQ:IDRA) yearly performance is 444.26%.
Levi & Korsinsky on Apr. 10 announced that a class action lawsuit has been commenced in the United States District Court for the District of Oregon on behalf of holders of Galena Biopharma, Inc. (NASDAQ:GALE) securities between November 6, 2013 and February 14, 2014.Galena Biopharma Inc (NASDAQ:GALE) shares moved up 12.43% in last trading session and was closed at $2.08, while trading in range of $ 1.85 – 2.12. Galena Biopharma Inc (NASDAQ:GALE) year to date (YTD) performance is -10.43%.
Equities researchers at Deutsche Bank lifted their target price on shares of Sarepta Therapeutic (NASDAQ:SRPT) from $17.00 to $35.00 in a research report issued on Tuesday, Stock Ratings Network reports. The firm currently has a “hold” rating on the stock. Deutsche Bank’s target price would indicate a potential upside of 3.00% from the company’s current price. Sarepta Therapeutics Inc (NASDAQ:SRPT) weekly performance is 74.02%. On last trading day company shares ended up $38.79. Sarepta Therapeutics Inc (NASDAQ:SRPT) distance from 50-day simple moving average (SMA50) is 46.38%. Analysts mean target price for the company is $25.50.
Leave a Reply